Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients

Document overview

Summary

Section 1 . Purpose. The United States has less than five percent of the world's population and yet funds around three quarters of global pharmaceutical profits. This egregious imbalance is orchestrated through a purposeful scheme in which drug manufacturers deeply discount their products to access foreign markets, and subsidize that decrease through enormously high prices in the United States. The United States has for too long turned its back on Americans, who unwittingly sponsor both drug manufacturers and other countries.…

When the Federal Register does not provide a substantive abstract, Civixly selects a meaningful passage from the official text or clearly labels a title-based fallback.